Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl (1S)-1-((2S,4S)-5-oxo-4-(4-(pyridin-2-yl)benzyl)tetrahydrofuran-2-yl)-2-phenylethylcarbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

905836-53-5

Post Buying Request

905836-53-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

905836-53-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 905836-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,8,3 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 905836-53:
(8*9)+(7*0)+(6*5)+(5*8)+(4*3)+(3*6)+(2*5)+(1*3)=185
185 % 10 = 5
So 905836-53-5 is a valid CAS Registry Number.

905836-53-5Relevant academic research and scientific papers

2-pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects

DeGoey, David A.,Grampovnik, David J.,Flentge, Charles A.,Flosi, William J.,Chen,Yeung, Clinton M.,Randolph, John T.,Klein, Larry L.,Dekhtyar, Tatyana,Colletti, Lynn,Marsh, Kennan C.,Stoll, Vincent,Mamo, Mulugeta,Morfitt, David C.,Nguyen, Bach,Schmidt, James M.,Swanson, Sue J.,Mo, Hongmei,Kati, Warren M.,Molla, Akhteruzzaman,Kempf, Dale J.

experimental part, p. 2571 - 2586 (2010/02/28)

A series of symmetry-based HIV protease inhibitors was designed and synthesized. Modification of the core regiochemistry and stereochemistry significantly affected the potency, metabolic stability, and oral bioavailability of the inhibitors, as did the variation of a pendent arylmethyl P3 group. Optimization led to the selection of two compounds, 10c (A-790742) and 9d (A-792611), for advancement to preclinical studies. Both compounds displayed low nanomolar potency against wild type HIV in the presence of human serum, low rates of metabolism in human liver microsomes, and high oral bioavailability in animal models. The compounds were examined in a preclinical model for the hyperbilirubinemia observed with some HIV PIs, and both exhibited less bilirubin elevation than comparator compounds. X-ray crystallographic analyses of the new cores were used to examine differences in their binding modes. The antiviral activity of the compounds against protease inhibitor resistant strains of HIV was also determined.

An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611

Engstrom, Kenneth,Henry, Rodger,Hollis, L. Steven,Kotecki, Brian,Marsden, Ian,Pu, Yu-Ming,Wagaw, Seble,Wang, Weifeng

, p. 5369 - 5372 (2007/10/03)

A stereoselective synthesis of the hydroxyethylene dipeptide isostere 1 is described. The route employs a substrate-directed kinetic protonation of an α/γ-substituted lactone to afford the desired stereochemistry. A method for converting the diastereomeri

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 905836-53-5